• Je něco špatně v tomto záznamu ?

European guideline and expert statements on the management of narcolepsy in adults and children

CLA. Bassetti, U. Kallweit, L. Vignatelli, G. Plazzi, M. Lecendreux, E. Baldin, L. Dolenc-Groselj, P. Jennum, R. Khatami, M. Manconi, G. Mayer, M. Partinen, T. Pollmächer, P. Reading, J. Santamaria, K. Sonka, Y. Dauvilliers, GJ. Lammers

. 2021 ; 28 (9) : 2815-2830. [pub] 20210625

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, systematický přehled

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003804

BACKGROUND AND AIM: Narcolepsy is an uncommon hypothalamic disorder of presumed autoimmune origin that usually requires lifelong treatment. This paper aims to provide evidence-based guidelines for the management of narcolepsy in both adults and children. METHODS: The European Academy of Neurology (EAN), European Sleep Research Society (ESRS) and European Narcolepsy Network (EU-NN) nominated a task force of 18 narcolepsy specialists. According to the EAN recommendations, 10 relevant clinical questions were formulated in PICO format. Following a systematic review of the literature (performed in Fall 2018 and updated in July 2020) recommendations were developed according to the GRADE approach. RESULTS: A total of 10,247 references were evaluated, 308 studies were assessed and 155 finally included. The main recommendations can be summarized as follows: (i) excessive daytime sleepiness in adults-scheduled naps, modafinil, pitolisant, sodium oxybate (SXB), solriamfetol (all strong), methylphenidate, amphetamine derivates (both weak); (ii) cataplexy in adults-SXB, venlafaxine, clomipramine (all strong) and pitolisant (weak); (iii) excessive daytime sleepiness in children-scheduled naps, SXB (both strong), modafinil, methylphenidate, pitolisant, amphetamine derivates (all weak); (iv) cataplexy in children-SXB (strong), antidepressants (weak). Treatment choices should be tailored to each patient's symptoms, comorbidities, tolerance and risk of potential drug interactions. CONCLUSION: The management of narcolepsy involves non-pharmacological and pharmacological approaches with an increasing number of symptomatic treatment options for adults and children that have been studied in some detail.

AP HP Pediatric Sleep Center CHU Robert Debré Paris France

Center for Mental Health Klinikum Ingolstadt Ingolstadt Germany

Center for Narcolepsy Hypersomnias Clin Sleep and Neuroimmunology Institute of Immunology University Witten Herdecke Witten Germany

Center of Sleep Medicine Sleep Research and Epileptology Clinic Barmelweid Barmelweid Switzerland

Danish Center for Sleep Medicine Department of Clinical Neurophysiology Faculty of Health Sciences Rigshospitalet University of Copenhagen Copenhagen Denmark

Department of Biomedical Metabolic and Neural Sciences University of Modena and Reggio Emilia Modena Italy

Department of Clinial Neurosciences Clinicum Helsinki Sleep Clinic Vitalmed Research Center Terveystalo Biobank and Clinical Research University of Helsinki Helsinki Finland

Department of Neurology and Center of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Neurology Faculty of Medicine University of Ljubljana Ljubljana Slovenia

Department of Neurology Inselspital Bern University Hospital and University of Bern Bern Switzerland

Department of Neurology James Cook University Hospital Middlesbrough UK

Department of Neurology Leiden University Medical Centre Leiden The Netherlands

Department of Neurology Philipps Universität Marburg Marburg Germany

Institute of Clinical Neurophysiology University Medical Centre Ljubljana Ljubljana Slovenia

IRCCS Istituto delle Scienze Neurologiche di Bologna UOC Clinica Neurologica Bologna Italy

National Reference Centre for Orphan Diseases Narcolepsy Idiopathic Hypersomnia and Kleine Levin Syndrome Paris France

National Reference Centre for Orphan Diseases Narcolepsy Idiopathic Hypersomnia Sleep Unit Department of Neurology Gui de Chauliac Hospital CHU Montpellier University of Montpellier INM INSERM Montpellier France

Neurology Department Hephata Klinik Schwalmstadt Germany

Neurology Service Hospital Clínic of Barcelona Barcelona Spain

Sleep Center Faculty of Biomedical Sciences Neurocenter of Southern Switzerland Università della Svizzera Italiana Lugano Switzerland

Sleep Wake Centre SEIN Heemstede The Netherlands

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003804
003      
CZ-PrNML
005      
20220127145838.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/ene.14888 $2 doi
035    __
$a (PubMed)34173695
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Bassetti, Claudio L A $u Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland
245    10
$a European guideline and expert statements on the management of narcolepsy in adults and children / $c CLA. Bassetti, U. Kallweit, L. Vignatelli, G. Plazzi, M. Lecendreux, E. Baldin, L. Dolenc-Groselj, P. Jennum, R. Khatami, M. Manconi, G. Mayer, M. Partinen, T. Pollmächer, P. Reading, J. Santamaria, K. Sonka, Y. Dauvilliers, GJ. Lammers
520    9_
$a BACKGROUND AND AIM: Narcolepsy is an uncommon hypothalamic disorder of presumed autoimmune origin that usually requires lifelong treatment. This paper aims to provide evidence-based guidelines for the management of narcolepsy in both adults and children. METHODS: The European Academy of Neurology (EAN), European Sleep Research Society (ESRS) and European Narcolepsy Network (EU-NN) nominated a task force of 18 narcolepsy specialists. According to the EAN recommendations, 10 relevant clinical questions were formulated in PICO format. Following a systematic review of the literature (performed in Fall 2018 and updated in July 2020) recommendations were developed according to the GRADE approach. RESULTS: A total of 10,247 references were evaluated, 308 studies were assessed and 155 finally included. The main recommendations can be summarized as follows: (i) excessive daytime sleepiness in adults-scheduled naps, modafinil, pitolisant, sodium oxybate (SXB), solriamfetol (all strong), methylphenidate, amphetamine derivates (both weak); (ii) cataplexy in adults-SXB, venlafaxine, clomipramine (all strong) and pitolisant (weak); (iii) excessive daytime sleepiness in children-scheduled naps, SXB (both strong), modafinil, methylphenidate, pitolisant, amphetamine derivates (all weak); (iv) cataplexy in children-SXB (strong), antidepressants (weak). Treatment choices should be tailored to each patient's symptoms, comorbidities, tolerance and risk of potential drug interactions. CONCLUSION: The management of narcolepsy involves non-pharmacological and pharmacological approaches with an increasing number of symptomatic treatment options for adults and children that have been studied in some detail.
650    _2
$a dospělí $7 D000328
650    12
$a kataplexie $7 D002385
650    _2
$a dítě $7 D002648
650    _2
$a lidé $7 D006801
650    _2
$a modafinil $x terapeutické užití $7 D000077408
650    12
$a narkolepsie $x diagnóza $x farmakoterapie $7 D009290
650    _2
$a spánek $7 D012890
650    12
$a oxybát sodný $x terapeutické užití $7 D012978
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a systematický přehled $7 D000078182
700    1_
$a Kallweit, Ulf $u Center for Narcolepsy/Hypersomnias, Clin. Sleep and Neuroimmunology, Institute of Immunology, University Witten/Herdecke, Witten, Germany
700    1_
$a Vignatelli, Luca $u IRCCS, Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy
700    1_
$a Plazzi, Giuseppe $u IRCCS, Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy $u Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
700    1_
$a Lecendreux, Michel $u AP-HP, Pediatric Sleep Center, CHU Robert-Debré, Paris, France $u National Reference Centre for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia and Kleine-Levin Syndrome (CNR narcolepsie-hypersomnie), Paris, France
700    1_
$a Baldin, Elisa $u IRCCS, Istituto delle Scienze Neurologiche di Bologna, UOC Clinica Neurologica, Bologna, Italy
700    1_
$a Dolenc-Groselj, Leja $u Institute of Clinical Neurophysiology, University Medical Centre Ljubljana, Ljubljana, Slovenia $u Department of Neurology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
700    1_
$a Jennum, Poul $u Danish Center for Sleep Medicine, Department of Clinical Neurophysiology, Faculty of Health Sciences, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
700    1_
$a Khatami, Ramin $u Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland $u Center of Sleep Medicine, Sleep Research and Epileptology. Clinic Barmelweid, Barmelweid, Switzerland
700    1_
$a Manconi, Mauro $u Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland $u Sleep Center, Faculty of Biomedical Sciences, Neurocenter of Southern Switzerland, Università della Svizzera Italiana, Lugano, Switzerland
700    1_
$a Mayer, Geert $u Neurology Department, Hephata Klinik, Schwalmstadt, Germany $u Department of Neurology, Philipps-Universität Marburg, Marburg, Germany
700    1_
$a Partinen, Markku $u Department of Clinial Neurosciences, Clinicum, Helsinki Sleep Clinic, Vitalmed Research Center, Terveystalo Biobank and Clinical Research, University of Helsinki, Helsinki, Finland
700    1_
$a Pollmächer, Thomas $u Center for Mental Health, Klinikum Ingolstadt, Ingolstadt, Germany
700    1_
$a Reading, Paul $u Department of Neurology, James Cook University Hospital, Middlesbrough, UK
700    1_
$a Santamaria, Joan $u Neurology Service, Hospital Clínic of Barcelona, Barcelona, Spain
700    1_
$a Sonka, Karel $u Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Dauvilliers, Yves $u National Reference Centre for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia, Sleep Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, INM INSERM, Montpellier, France
700    1_
$a Lammers, Gert J $u Sleep Wake Centre SEIN, Heemstede, The Netherlands $u Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands
773    0_
$w MED00001629 $t European journal of neurology $x 1468-1331 $g Roč. 28, č. 9 (2021), s. 2815-2830
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34173695 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145835 $b ABA008
999    __
$a ok $b bmc $g 1751309 $s 1154953
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 28 $c 9 $d 2815-2830 $e 20210625 $i 1468-1331 $m European journal of neurology $n Eur J Neurol $x MED00001629
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace